PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 20260 citations

Bloodstream infection by Fusarium Solani Complex in a paediatric patient affected by acute lymphoblastic leukaemia and P450 cytochrome polymorphism: A case report

View Full Paper
DFDe Leonardis F.MGMiani V. G.DVDe Laurentiis V.

Key Points

  • To report an invasive Fusarium bloodstream infection in a pediatric patient with acute lymphoblastic leukaemia.
  • Case presentation of an eleven-year-old male with high-risk acute lymphoblastic leukaemia.
  • Employed genetic analysis to determine CYP2C19 polymorphism.
  • Monitored therapeutic drug levels during antifungal treatment.
  • Fusarium solani complex identified in blood cultures.
  • Initial voriconazole therapy resulted in low plasma levels; treatment switched to liposomal amphotericin B.
  • Clinical recovery achieved after the change in therapy.

Abstract

Background and Purpose: Fusarium species are causative agents of a wide range of opportunistic infections, ranging from superficial to disseminated forms, particularly in nosocomial settings. Children with haematological malignancies may develop severe fungal infections, such as fusariosis, that have proven notoriously challenging to diagnose and treat, with high mortality rates. Case Presentation: This report aimed to describe an invasive Fusarium bloodstream infection in an eleven-year-old male patient treated for high-risk acute lymphoblastic leukaemia. The patient presented with neutropenic fever and necrotic papular skin lesions. Fusarium solani complex was identified in blood cultures. Initial empirical therapy with voriconazole led to partial improvement, but therapeutic drug monitoring showed persistently low plasma levels. Genetic analysis revealed CYP2C19*17 polymorphism, classifying the patient as an ultrarapid metabolizer. Treatment was switched to liposomal amphotericin B, resulting in clinical recovery. Conclusion: This case highlighted the importance of early diagnosis, targeted antifungal treatment, therapeutic drug monitoring, and pharmacogenetic testing in pediatric Fusarium infections.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

F. et al. (2026) studied this question.

synapsesocial.com/papers/6a095c147880e6d24efe2154https://doi.org/10.22034/cmm.2025.345277.1568
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acute lymphoblastic leukemia with Fusarium solani infection: a case report2025
  2. 221-plex PCR and Antifungal Susceptibility Aspects of Fungemia Agents in Pediatric Patients with Hematological Malignancies: A Single-Center Experience2024
  3. 3Invasive Fusarium Infections in Immunocompromised Children2026
  4. 4Successful Treatment of Disseminated Fusariosis in a 15-Month-old Boy With Refractory Acute Lymphoblastic Leukemia Using High-dose Voriconazole2024 · 3 citations
  5. 5Landscape of Invasive Fusariosis in Pediatric Cancer Patients: Results of a Multicenter Observational Study From Latin America2024 · 5 citations